Floatz logo

DESFERRIOXAMINE B

Acute Intracerebral Haemorrhage

The George InstituteSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Acute Intracerebral Haemorrhage cohort.

Asset / SponsorPhaseRating
COLCHICINUM
Population Health Research Institute
Phase 3B

Same molecule, other indications

DESFERRIOXAMINE B is also rated in:

beta-thalassemia majorDormant
BBB
Indicative ·
75 / 100
View asset →
iron metabolism diseaseDormant
BBB
Indicative ·
73 / 100
View asset →
hemosiderosisDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →